CAJ | 학술논문

目的探讨超短波联合肺功能训练对慢性阻塞性肺疾病(COPD)患者肺功能及生活质量的影响.方法将90例稳定期COPD患者随机分成联合治疗组、家庭训练组及对照组,每组30例.3组患者均给予常规内科治疗,联合治疗组同时辅以家庭肺功能训练及超短波治疗,家庭训练组则同时给予家庭肺功能训练.于治疗前及治疗6个月后检测各组患者肺功能及膈肌功能改善情况,同时采用圣·乔治呼吸问卷(SGRQ)对各组患者生活质量进行评定.结果 3组患者经治疗6个月后,发现联合治疗组及家庭训练组FEV1占预计值%、FEV1/FVC%均较治疗前明显提高,SGRQ评分显著降低.并且以联合治疗组FEV1占预计值%及SGRQ评分的改善幅度较显著,与家庭训练组间差异具有统计学意义(均P<0.05);对照组FEV1占预计值%、FEV1/FVC%及SGRQ评分治疗前后均无明显改变;3组患者治疗前后膈肌功能均无明显变化.结论超短波联合家庭肺功能训练对治疗COPD具有协同功效,能显著改善患者肺功能及生活质量.
목적 탐토초단파연합폐공능훈련대만성조새성폐질병(COPD)환자폐공능급생활질량적영향.방법 장90례은정기COPD환자수궤분성연합치료조、가정훈련조급대조조,매조30례.3조환자균급여상규내과치료,연합치료조동시보이가정폐공능훈련급초단파치료,가정훈련조칙동시급여가정폐공능훈련.우치료전급치료6개월후검측각조환자폐공능급격기공능개선정황,동시채용골·교치호흡문권(SGRQ)대각조환자생활질량진행평정.결과 3조환자경치료6개월후,발현연합치료조급가정훈련조FEV1점예계치%、FEV1/FVC%균교치료전명현제고,SGRQ평분현저강저.병차이연합치료조FEV1점예계치%급SGRQ평분적개선폭도교현저,여가정훈련조간차이구유통계학의의(균P<0.05);대조조FEV1점예계치%、FEV1/FVC%급SGRQ평분치료전후균무명현개변;3조환자치료전후격기공능균무명현변화.결론 초단파연합가정폐공능훈련대치료COPD구유협동공효,능현저개선환자폐공능급생활질량.
Objective To investigate the effects of ultrashortwave therapy associated with home-based rehabilitation on lung function and quality of life (QOL) in chronic obstructive pulmonary disease (COPD) patients. Methods Ninety patients with stable COPD were equally and randomly divided into a combination group (received uhrashortwave therapy combined with home-based rehabilitation and regular treatment), a rehabilitation group (received home-based rehabilitation and regular treatment), and a control group ( received regular treatment). Spirometry and diaphragm function were measured, and St George's respiratory questionnaire (SGRQ) was administered for QOL assessment at the beginning and after 6-month of treatment. Results FEVI% pred and FEV1% increased and average SGRQ scores decreased in the combination group and rehabilitation group. FEVI% pred and SGRQ scores improved most in combination group (all P < 0.05 ). FEV1% pred, FEV1 % and SGRQ scores in control group did not show any obvious change. Diaphragm function in all groups did not change significantly. Conclusions Ultra-shortwave therapy combined with home-based rehabilitation might have combinative effects in improving lung function and QOL of COPD patients.